GPT Healthcare IPO

GPT Healthcare Limited

₹14,160 /80 sharesMinimum Investment

GPT Healthcare IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
22 Feb ‘24 - 26 Feb ‘24₹14,16080₹177 - ₹186
Issue SizeIPO Doc
525.14Cr
RHP PDF

Subscription rate

Qualified Institutional Buyers17.30x
Non-Institutional Investor11.02x
Retail Individual Investor2.44x
Total8.52x

About GPT Healthcare

GPT Healthcare Limited is a healthcare player in Eastern India with four mid-sized full-service hospitals in West Bengal and Tripura, offering 561 beds in total. The company offers secondary and tertiary care across 35 specialties under the brand name ILS Hospitals. The company’s offerings include intensive care, neurology, nephrology (including kidney transplant), orthopaedics and joint replacement, internal medicine and diabetology, neurosurgery, integrated diagnostic services, gynaecology and obstetrics, laparoscopic and general surgery, gastroenterology, interventional cardiology, paediatrics, neonatology and pharmacy services.;
Founded in
1989
Managing director
Dr. Om Tantia
Parent organisation
GPT Healthcare Limited

Strengths & Financials of GPT Healthcare

Strengths
Risks
As per a CRISIL report for Fiscal year 2023, GPT Healthcare is one of the key regional corporate healthcare companies in Eastern India in terms of number of beds and hospitals. The company has been operational in the region for the past 20 years.
The company has a diversified service portfolio as a multispecialty healthcare platform. This has allowed it to have diversified revenue streams. In addition to providing core medical, surgical, and emergency services, it provides complex and advanced healthcare in specialities, such as nephrology (including renal transplants), diabetology etc.
The company has expanded over the years by increasing the bed capacity of its hospitals from eight beds in July 2000 to 561 beds as of September 30, 2023. Its team of medical professionals have also increased over the years. From a staff of 945 in 2021, the company has a team of 1312 medical professionals as of Sep 30, 2023.
It reported total operational revenues of Rs. 361.04 cr, Rs. 337.42 cr, and Rs. 242.75 cr, for Fiscal Years 2023, 2022, and 2021 respectively.

GPT Healthcare Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of GPT Healthcare IPO

Apply asPrice bandApply upto
Regular177 - 186₹2 Lakh
High Networth Individual177 - 186₹2 - 5 Lakh
For GPT Healthcare IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.6.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW